Stocks · News reference
Emergent BioSolutions Receives Canada's Offer To Provide NARCAN Nasal Spray, Effective Oct. 1 Through September 2029
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a standing offer by the Government of Canada, through a competitive procurement process, to supply NARCAN® Nasal Spray. The standing offer
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Emergent Biosolutions Appoints Treasurer Frank Vargo As Interim CFO, Effective Jan. 1, 2027, Succeeding Richard Lindahl
https://www.sec.gov/ix?doc=/Archives/edgar/data/1367644/000136764426000098/ebs-20261016.htm
8-K filing — Emergent BioSolutions Inc. (EBS)
Filed: 2026-10-16 AccNo: 0001367644-26-000098 Size: 213 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
'Russia Denies Report of Second Case of Illness in Siberia' - Bloomberg
https://www.bloomberg.com/news/articles/2026-10-08/russia-denies-report-of-second-case-of-illness-in-siberia